Clearday (CLRD:OTC EXMKT), a tech-centric healthcare services company, has provided an update on its business combination with Viveon Healthcare Acquisition (VHAQ:OTC EXMKT). The company has developed software and digital assistants for the Senior Living sector, delivering therapies and engagement via tablets, smartTVs, and companion robotics. Both companies are working towards completing the combination, which includes listing the combined company's stock on NASDAQ or NYSE American.
Clearday's CEO, James Walesa, acknowledged the challenging financing environment but reaffirmed the company's commitment to the deal. He emphasized that Clearday stockholders will receive shares in the combined company on a pro-rata basis, independent of Clearday's current stock value. The company is also taking steps to complete SEC filings to allow trading on the Pink OTC Market.
Clearday (OTC: CLRD) aligns with the Office of Disease Prevention and Health Promotion to support National Health Observances (NHOs), focusing on Alzheimer's Disease and brain health in June. CEO Jim Walesa emphasized Clearday’s commitment to brain health year-round through innovative technologies for caregivers. The company will host related programs in Texas and Florida and release a series of press updates detailing Clearday’s role in dementia care, innovations, and future visions. Stakeholders are encouraged to follow these updates on Clearday’s website.
Clearday announces the resignation of Board Member Jeff Coleman, thanking him for his service since 2021. The company plans to add a new director to support the Business Combination with Viveon Healthcare Acquisition Corp, focusing on advancements in Digital Assistants and aging applications to drive new revenue streams.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.